MONDAY, March 30 (HealthDay News) — U.S. researchers say they’ve spotted new gene variations that could boost the risk of sporadic breast cancer.

Researchers have identified a new marker for breast cancer metastasis called TMEM, for Tumor Microenvironment of Metastasis. Density of TMEM was found to be associated with the development of distant organ metastasis via the bloodstream — the most common cause of death from breast cancer.

Combining a compound known as a gallium corrole with a protein carrier results in a targeted cancer therapy that is able to detect and eliminate tumors in mice with seemingly fewer side effects than other breast-cancer treatments, according to new research.

Dozens of B.C. breast cancer cases are under review after a B.C. pathologist alleged that substandard breast cancer testing was taking place in the province.

More than 100 breast cancer patients tested at Kelowna General Hospital may be at risk from analytic errors, according to a former clinical director of Okanagan Heath Service Area laboratories.